9348. Misbranding of Pildoras Uriseptic.   U. S.   *   *   *   v. 12 Dozen Bottles and 35 Bottles
of Pildoras Uriseptic. Consent decrees of condemnation and forfeiture. Product 
released under bond. (F. & D. Nos. 14264, 14278. I. S. Nos. 9759-t, 9767-t. S. Nos. E-3018, 
E-3067.)
On January 25 and 28, 1921, respectively, the United States attorney for the Dis- 
trict of Porto Rico, acting upon reports by the Secretary of Agriculture, filed in the 
District Court of the United States for said district libels, and on February 12, 1921, an 
amended libel in the latter case, for the seizure and condemnation of 12 dozen bottles 
and 35 bottles of Pildoras Uriseptic, remaining in the original unbroken packages 
at San Juan and Mayaguez, P. R., respectively, alleging that the former had been 
shipped by the France and New York Medicine Co., New York, N. Y., on or about 
July 22, 1920, and that the latter had been shipped by the Davis & Lawrence Co., 
New York, N. Y., on or about November 30, 1920, and that both consignments had 
been transported from the State of New York into the Island of Porto Rico, and 
charging misbranding in violation of the Food and Drugs Act, as amended. The 
consignment of July 22 was labeled in part: (Bottle label, in Spanish) "Uriseptic 
Pills. Used in the treatment of gonorrhea, inflammations of the bladder or urethra 
and other forms of secondary diseases which usually follow blennorrhagic infection. 
* * * Uriseptic Pills * * * Anti-Gonorrheic, * * *." The consignment of 
November 30 was labeled in part: (Carton) "Uriseptic Pills, Antiseptic, Anti-Gonor- 
•rheal, Diuretic, Resolvent * * * By purchasing this original package the public 
are enabled to obtain the standard remedy for the treatment of the above com- 
plaints, * * *" (similar statements in Dutch, French and Spanish); (bottle) 
"Uriseptic Pills. Anti-Gonorrheal, Diuretic, Antiseptic, Resolvent. * * * 
cannot be surpassed by any other for the treatment of Gonorrhea, or in the treatment 
of chronic or acute inflammations of the Bladder or urethra and other forms of second- 
ary diseases which generally result from blennorrhagic infection * * *;" (circular) 
"* * * Uriseptic Pills * * * Used in the treatment of Gonorrhea, Diuretic, 
Antiseptic, Resolvent.   *   *   *   If Uriseptic Pills are taken regularly, the disease
is attacked in a rational way, and beneficial results may be expected in ordinary 
cases. Frequently chronic cases—those which have been treated with injections or 
which have not been attended regularly—will yield, with the use of Uriseptic Pills.
* * * In many cases in which the patient conducts himself properly, that is, 
abstaining from alcoholic drinks, violent exercise, and taking Uriseptic Pills as per 
instructions, the results are beneficial. Uriseptic Pills are likewise used in acute as 
well as in chronic cases, since they counteract the disease in a purely natural manner.
* * * In Cystitis * * * Uriseptic Pills may be used. * * * Uriseptic 
Pills, * * * represent modern ideas of treatment. Uriseptic Pills exert no preju- 
dicial action on the stomach and do not derange digestion. * * * Uriseptic Pills— 
a formula which represents efficacious agents to combat this disease—in the hands of 
the most experienced and conscientious physicKans. Uriseptic Pills will be found 
of value   *   *   *."
Analysis of a sample of the article by the Bureau of Chemistry of this department 
showed that the pills consisted essentially of cubebs, methylene blue, salol, and 
kava kava.
Misbranding of the article was alleged in substance in the libels for the reason that 
the above-quoted statements regarding the curative and therapeutic effects thereof 
were false and fraudulent, as the article contained no ingredient or combination of 
ingredients capable of producing the effects claimed.
On March 14, 1921, the Davis & Lawrence Co., New York, N. Y., claimant, having 
consented to the entry of decrees in the respective cases, and having failed to deny 
the allegations contained in the libels, judgments of condemnation and forfeiture 
were entered, and it was ordered by the court that the product be released to said 
claimant upon payment of the costs of the proceedings and the execution of bonds in 
the aggregate sum of $200, in conformity with section 10 of the act.
E. D. BALL, Acting Secretary of Agriculture.